Annual Report of the Academic Output of DCRI Clinical ...

Annual Report of the Academic Output of DCRI Clinical Research FellowsAcademic Year: July 2012 – June 2013

AKSHAY BAGAI, MD — CO-CHIEF FELLOW

TRAINING

Medical School (1999–2003): University of Toronto, Canada

Residency in Internal Medicine (2003–2006): University of Toronto, Canada

Cardiology Fellowship (2006–2009): University of Toronto, Canada

Interventional Cardiology Fellowship (2011–2013): St. Michael’s Hospital, Toronto, Canada

Clinical Research Fellowship (2011–2013): Duke Clinical Research Institute, Durham, NC

AWARDS/GRANTS

3rd place, Northwestern Cardiovascular Young Investigator Forum (2012)

QUANTITATIVE TRAINING

Clinical Research Training Program, Masters in Health Sciences Degree (2013): Duke University School of Medicine

CONNIE N. HESS, MD, MHS — CO-CHIEF FELLOW

TRAINING

Medical School (2000–2005): Harvard Medical School, Boston, MA

Residency in Medicine (2005–2008): Massachusetts General Hospital, Boston, MA

Postdoctoral Research Fellowship (2008–2009): Brigham and Women’s Hospital, Boston, MA

Cardiology Fellowship (2009–2013): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

Ruth L. Kirschstein NRSA Institutional Research Training Grant (T32), Division of Cardiology, Duke University Medical Center, Durham, NC

American College of Cardiology Foundation/Bristol-Myers Squibb Travel Award, 2013 Scientific Sessions of the American College of Cardiology

DCRI and Duke Division of Cardiology/Heart Center Clinical Research Support Award (2013)

Robert A. Harrington Excellence in Fellowship Award (2013)


Clinical Research Training Program, Masters of Health Sciences Degree (2013): Duke University School of Medicine

TARIQ AHMAD, MD, MPH

TRAINING

Medical School (2002–2006): SUNY Stony Brook School of Medicine, Stony Brook, NY

Internal Medicine Residency (2006–2010): Brigham and Women’s Hospital, Boston, MA

Cardiology Fellowship (2010–present): Duke University Medical Center, Durham, NC

Clinical Research Fellowship (2012–present): Duke Clinical Research Institute, Durham, NC

AWARDS/GRANTS

NIH Loan Repayment Grant (2012–2014)

Duke Heart Center Clinical Research Grant Recipient

Daland Fellowship in Clinical Research (2012–2014)

ACC Cardiosource Up and Coming Cardiology Fellow

JACC Heart Failure Fellow

ACCF/Bristol-Myers Squibb Travel Award

Russek Fellow

Best Fellow in Training Poster, American College of Cardiology Meeting (2013)


Coursework in the Clinical Research Training Program, Duke University School of Medicine

MONIQUE L. ANDERSON, MD

TRAINING

Medical School (2001–2006): Harvard Medical School, Boston, MA

Residency (2006–2009): Vanderbilt Medical Center, Nashville, TN



AWARDS/GRANTS

National Institutes of Health Loan Repayment Award (2012)

American Heart Association-Pharmaceutical Roundtable (AHA-PRT) Outcomes Research Fellowship (2011–2013): Duke Clinical Research Institute

AHA 3CPR Council Best Resuscitation Abstract Award (2012)

AHA Cardiology Minority Travel Grant, Council on Clinical Cardiology (2012)


Clinical Research Training Program, Masters of Health Sciences Degree (Anticipated 2013): Duke University School of Medicine

JULIE AUTMIZGUINE, MD, FRCPC

TRAINING

Medical School (2002–2006): University Of Sherbrooke, Quebec, Canada

Residency in Pediatrics (2006–2009): University Of Montreal, Quebec, Canada

Pediatric Infectious Disease Fellowship (2009–2012): University Of Montreal, Quebec, Canada


AWARDS/GRANTS

Training Award, Fonds Irma-Levasseur, Pediatric Department, Sainte-Justine University Hospital Center (2012–2013)

Trainee Travel Grant: ID Week (2012)


Clinical Research Training Program, Duke University School of Medicine

JESSE BAIN, DO

TRAINING

Medical School (2002–2006): New York College of Osteopathic Medicine, Old Westbury, NY

Residency in Combined Internal Medicine-Pediatrics (2006–2010): Maine Medical Center, Portland, ME

Pediatric Critical Care Fellowship: (2010–2013): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

NIH T-32 Training Grant (2011–2012): Received salary support from the Department of Pediatrics, Institutional Training Award


Classwork in the Master’s Program for Economics, North Carolina State University

GWEN BERNACKI, MD, MHSA

TRAINING

Master of Health Services Administration (1998–2000): University of Michigan, Ann Arbor, Michigan

Medical School (2003–2007): University at Buffalo, Buffalo, New York

Internal Medicine Residency (2007–2010): University of Washington, Seattle, Washington

Cardiology Fellowship (2010–2013): Duke University, Durham, North Carolina


AWARDS/GRANTS

American College of Cardiology Fellows in Training Representative of the Council on the Cardiovascular Care of Older Adults (2013–2014)

American College of Cardiology Geriatric Cardiology Fellows in Training Retreat Co-Chair (2013)

American College of Cardiology Foundation Women’s Career and Leadership Development Conference Scholarship (2013)

Hartford Interdisciplinary Scholars Communications Conference Scholarship (2013)

Hartford Scholar in the Center of Excellence in Geriatric Medicine and Training program at Duke University (2012)

Duke/UNC T32 Clinical Pharmacology Training Grant Recipient (2012–2013)

FLAVIO DE SOUZA BRITO, MD

TRAINING

Medical School (2000–2005): State University of São Paulo-UNESP, Botucatu, Brazil

Residency in Medicine (2006–2008): State University of São Paulo-UNESP, Botucatu, Brazil

Cardiology Fellowship: (2008–2010): Federal University of São Paulo-UNIFESP, São Paulo, Brazil

Heart Failure and Heart Transplant Fellowship (2010–2011): Federal University of São Paulo-UNIFESP, São Paulo, Brazil


AWARDS/GRANTS

Scholarship, CNPq- National Board for Development of Science and Technology, Ministry for Science and Technology of Brazil (2013–present)

Research grant, Society of Cardiovascular Patient Care (2013)

MICHAELA A. DINAN, PHD

TRAINING

PhD, Health Policy and Management (2006–2011): University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC

AWARDS/GRANTS

AHRQ; ID: Patient Centered Outcomes Research (PCOR) Pathway to Independence Award (K99-R00) (2013–2018)

Duke Cancer Institute; ID: Duke Cancer Institute Pilot Cancer Control Studies (2013)

National Cancer Institute, ID: Comparative Effectiveness (CER) Mentored Career Development Awards (KM1) (2013)

BRIAN R. ENGLUM, MD

TRAINING

Medical School (2006–2010): Johns Hopkins School of Medicine, Baltimore, MD

Residency in General Surgery (2010–present): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

National Cancer Database Participant User File Award (2013)



DANIEL GONZALES, PHARMD, PHD

TRAINING

Pharmacy School (2004–08): University of Florida, Gainesville, FL

Graduate School (2008–12): University of Florida, Gainesville, FL


AWARDS/GRANTS

NIH T-32 Training Grant (2012–present): Received salary support from the UNC School of Pharmacy/DCRI training grant

SHARIF HALIM, MD, MHS

TRAINING

Medical School (2002–2006): Ohio State University, Columbus, OH

Residency in Medicine (2006–2009): Duke University Medical Center, Durham, NC



AWARDS/GRANTS

NIH T-32 Training Grant (2011–2013). Received salary support from the Division of Cardiology Institutional Training Award

American College of Cardiology Interventional Fellows Travel Award (2013)



RASHEEDA HALL, MD, MBA

TRAINING

Medical School (2001–2006): Vanderbilt University School of Medicine, Nashville, TN


Nephrology Fellowship (2009–2013): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

NIH/NIA Post-doctoral Diversity Supplement (2012–2013): Received salary support from Duke’s Claude D. Pepper Older Americans Independence Center P30 grant

American Society of Nephrology Advances in Geriatric Nephrology Seminar Travel Support Award (2012)

American Society Nephrology’s Dimitrios G. Oreopoulos Visiting Professor Program for Geriatric Nephrology (2013)

NIA Summer Institute on Aging Research: Selected to attend and receive travel support (2013)



ROBERT W. HARRISON, MD

TRAINING

Medical School (2001–2005) University of Maryland School of Medicine, Baltimore, MD

Residency (2005–2008): Internal Medicine, Duke University, Durham, NC

Chief Residency (2009–2010): Internal Medicine, Duke University, Durham, NC

Clinical Fellowship (2008–2009; 2010–2011): Cardiology, Duke University, Durham, NC




RALF E. HARSKAMP, MD

TRAINING

Medical School (2003–2010): University of Groningen, Groningen, Netherlands

Internship in cardiac surgery (2010): University of Utrecht, Utrecht, Netherlands


AWARDS

Best fellow-in-training poster at the 2013 American College of Cardiology research conference in San Francisco, CA

QUANTITATIVE TRIANING

PhD candidate, University of Amsterdam, Amsterdam, Netherlands

PAUL HESS, MD

TRAINING

Medical School (2000–2006): Emory University School of Medicine, Atlanta, GA

Residency in Medicine (2006–2009): Massachusetts General Hospital, Boston, MA

Cardiology Fellowship (2009–2013): Duke University Hospital, Durham, NC


QUANTITATIVE TRIANING


LISA JONES, MD

TRAINING

Medical School (2002–2006): Duke University Medical School, Durham, NC

Residency in Medicine (2006–2009): University of Pennsylvania, Philadelphia, PA

Gastroenterology Fellowship (2010–2013): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

NIDDK’s NIH/NMA Travel Award Recipient (2012)

FY12 Fellow Training Grant Incentive Program: Grant Awardee (2011)

Office of the National Coordinator (ONC) for Health IT Scholarship (2011)


Masters of Management in Clinical Informatics Degree (2013): Duke University Fuqua School of Business, Durham, NC

HYUN-JAE KANG, MD, PHD

TRAINING

Medical School (1990–1994): College of Medicine, Seoul National University, Seoul, South Korea

Residency in Internal Medicine (1995–1999): Seoul National University Hospital, Seoul, South Korea

Cardiology Clinical Fellowship (2002–2004): Seoul National University Hospital, Seoul, South Korea


PRATEETI KHAZANIE, MD, MPH

TRAINING

Medical School (2002–2006): Duke University School of Medicine, Durham, NC

Residency in Medicine (2006–2009): Stanford Medical Center, Stanford, CA

Chief Residency in Medicine (2009–2010): Stanford Medical Center, Stanford, CA



AWARDS/GRANTS

NIH T-32 Training Grant (2012–present): Received salary support from the Division of Cardiology Institutional Training Award

Medtronic-Duke Alliance Investigator Initiated Research Grant (MEDUSA grant) (2012)

American Heart Association—Council in Clinical Cardiology—Women in Cardiology Trainee Award for Excellence (2012)

MASAYA KOSHIZAKA, MD, PHD

TRAINING

Medical School (1996–2002): Ehime University, Ehime, Japan

Graduate School (2006–2010): Chiba University, Chiba, Japan

Residency in Medicine (2002–2006): Chiba University Hospital, Chiba, Japan

Endocrinology Fellowship (2006–2010): Chiba University Hospital, Chiba, Japan


GRANTS/AWARDS

Scholarship from the Japanese Society of Clinical Pharmacology and Therapeutics (2011–2013): Received salary support


Coursework in Clinical Research Training Program, Duke University School of Medicine

LAWRENCE KU, MD

TRAINING

Medical School (2005–2009): Wayne State University School of Medicine, Detroit, MI

Pediatrics Residency (2009–2012): Children’s Hospital of Michigan, Detroit, MI


AWARDS/GRANTS

NIH T-32 UNC-Duke Collaborative Clinical Pharmacology Training Grant. Received salary support from the multidisciplinary, collaborative pediatric clinical pharmacology training grant.

JIN A. LEE, MD, PHD

TRAINING

Medical School (1992–1996): Seoul National University, College of Medicine, Seoul, Korea

Internship: (1996–1997): Seoul National University Hospital, Seoul, Korea

Residency in Pediatrics (1998–2002): Seoul National University Hospital, Seoul, Korea

Clinical Fellowship (2002–2004): Division of Neonatology, Department of Pediatrics, Seoul National University Hospital, Seoul, Korea

Clinical Assistant Professor (2004–present): Department of Pediatrics, SNU-SMG Boramae Medical Center, Seoul, Korea


AWARDS/GRANTS

All financial support is from the SNU-SMG Boramae Medical Center


Coursework in the University of North Carolina at Chapel Hill School of Public Health

ROMITA MUKERJEE, MD, MHS

TRAINING

Medical School (2003–2007): Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA


Nephrology Fellowship (2010–present): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

AHRQ T-32 Training Grant (2011–present): Institutional National Research Service Award for Postdoctoral Comparative Effectiveness Research Training Program



EMILY O’BRIEN, PHD

TRAINING

MSPH, Epidemiology (2006–2008): University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC

PhD, Epidemiology (2009–2012): University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC

Postdoctoral Clinical Research Fellowship (2012–2013): Duke Clinical Research Institute, Durham, NC

AWARDS/GRANTS

American Heart Association, Get with the Guidelines Young Investigator Database Research Seed Grant (2013)

Duke University Postdoctoral Services Professional Development Award (2013)

PRIYESH A. PATEL, MD

TRAINING

Medical School (2005–2009): Duke University School of Medicine, Durham, NC

Residency in Internal Medicine (2009–2012): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

NIH T-32 Training Grant (2012–2013): Received salary support from Department of Cardiology Institutional Training Award

American Heart Association Get with the Guidelines Young Investigator Database Research Seed Grant (2012–2013)

Best of American Heart Association Specialty Conferences at Scientific Sessions — Awarded for top 10 percent of AHA Specialty Conferences Abstracts for QCOR Conference Abstract (2013)

Best Multi-disciplinary Teamwork to Improve Patient Safety and Quality at 2013 Duke Patient Safety Conference (2013)

AVINASH PATIL, MD

TRAINING

Medical School (2002–2006): University of Tennessee, Memphis, TN

Residency in Obstetrics and Gynecology (2006–2010): University of Tennessee, Memphis, TN

Maternal-Fetal Medicine Fellowship (2010–2013): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

NIH-NICHD Extramural Loan Repayment Program for Clinical Research (2011–2013)

NIH T-32 Training Grant. Received salary support from the UNC School of Pharmacy/DCRI training grant (2011–2013)


NIH-NIGMS T32 Clinical Pharmacology Fellowship Program (2011–2013): Duke University/University of North Carolina at Chapel Hill

MARIO SAMPSON, PHARMD

TRAINING

Doctor of Pharmacy (2007–2011): University of California School of Pharmacy, San Francisco, CA

Clinical Pharmacology Fellowship (2011–present): Duke Clinical Research Institute, Durham, NC/UNC Eshelman School of Pharmacy, Chapel Hill, NC

AWARDS/GRANTS

NIH T-32 Training Grant (2011–present): Received salary support from the UNC School of Pharmacy/DCRI training grant

LAN SHEN, MD, MHS

TRAINING

Medical School (2002–2007): Shanghai Jiaotong University, China

Residency in Medicine (2007–2009): Shanghai Renji Hospital, China

Cardiology Fellowship (2011–present): Shanghai Renji Hospital, China


AWARDS/GRANTS

Young Doctor Oversea Research Grant: Shanghai Renji Hospital, Cardiovascular Department, China


Clinical Research Training Program, Duke University School of Medicine (2011–2013)

ASHLEY SHERWOOD, MD

TRAINING

Medical School (2002–2006): New York College of Osteopathic Medicine, Old Westbury, NY

Residency in Pediatrics (2006–2010): Maine Medical Center, Portland, Maine

Pediatric Critical Care Fellowship (2010–2013): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

NIH T-32 Training Grant (2011–2012): Received salary support from the Department of Pediatrics, Institutional Training Award


Masters of Management in Clinical Informatics Degree (2013): Duke University Fuqua School of Business

MATTHEW W. SHERWOOD, MD

TRAINING

Medical School (2001–2006): Emory School of Medicine, Atlanta, GA

Residency in Internal Medicine (2006–2009): Brigham and Women’s Hospital, Boston, MA

Clinical Research Fellowship (2009–2010): TIMI Group/Brigham and Women’s Hospital, Boston, MA



AWARDS/FUNDING

NIH T-32 Training Grant (2012–2013): Received salary support from the Division of Cardiology Institutional Training Award

Walter L. Floyd Endowed Fellowship Award for Clinical Acumen from Duke University Division of Cardiology

American College of Cardiology Foundation/Bristol-Myers Squibb Travel Award, Scientific Sessions of the American College of Cardiology (2013)

American College of Cardiology Foundation Fellow-in-Training Travel Award to National Leadership Forum (2013)


Clinical Research Training Program: Duke University School of Medicine

BENJAMIN A. STEINBERG, MD

TRAINING

Medical School (2002–2007): Johns Hopkins University School of Medicine, Baltimore, MD

Residency (2007–2010): Johns Hopkins Hospital, Baltimore, MD

Cardiology Fellowship (2010–present), Duke University Medical Center, Durham, NC


AWARDS/GRANTS

National Institutes of Health Loan Repayment Program Award (2011–2013)

NIH T-32 Training Grant (2012–2013): Received salary support from the Division of Cardiology Institutional Training Award



DANIELA TESTONI, MD, MHS

TRAINING

Medical School (2000–2005): University of Campinas, Campinas, Brazil.

Pediatrics Residency (2006–2007): University of Campinas, Campinas, Brazil.

Neonatology Fellowship (2008–2009): Federal University of Sao Paulo, Sao Paulo, Brazil


AWARDS/GRANTS

2011–2013: Received salary support from Duke Clinical Research Institute Institutional Award

QUANTATITVE TRAINING


PhD in Pediatrics (2013–present): Federal University of Sao Paulo, Sao Paulo, Brazil

WAYNE M. TSUANG, MD

TRAINING

Medical School (2002–2007): Pritzker School of Medicine, Chicago, IL

Residency in Medicine (2007–2010): University of Cincinnati, Cincinnati, OH

Pulmonary Fellowship (2010–2013): Duke University Medical Center, Durham, NC


AWARDS/GRANTS

NIH T-32 Training Grant (2011–2013): Received salary support from the Division of Pulmonary and Critical Care Institutional Training Award

American Thoracic Society National Meeting Travel Award (2012): San Francisco, CA



YAMINI V. VIRKUD, MD, MA

TRAINING

Medical School (2004–2008): Washington University, St. Louis, MO

Residency in Pediatrics (2008–2011): St. Louis Children’s Hospital, St. Louis, MO


AWARDS/GRANTS

Domestic In-Training FITs/PhD Post Doc FITs Travel Scholarship, from the American Academy of Allergy, Asthma and Immunology (AAAAI) (2012)


UNC Public Health School, MPH in Biostatistics, (Anticipated 2014)

JIN WEN, PHD

TRAINING

School of Public Health (2002–2005): Sichuan University, Chengdu, China

School of Clinical Medicine (2005–2008): Sichuan University, Chengdu, China

Postdoctoral Fellowship at School of Business (2008–2010): Sichuan University, Chengdu, China


AWARDS/GRANTS

China Medical Board Faculty Development Project (2012)

Young Faculty Development Project of Sichuan University (2012–2013)


Health Sector Management Program (2012–2013): Fuqua School of Business, Duke University

Master of Global Health (2012–2013): Global Health Institute of Duke University

Master of Public Policy (2012–2013): Sanford School of Public Policy, Duke University

YEE WENG WONG, MBBS

TRAINING

Medical School (1999–2004): University of Adelaide, South Australia, Australia

Residency in Medicine (2006–2009): Royal Adelaide Hospital, South Australia, Australia

Cardiology Fellowship (2009–2011): Flinders Medical Center, South Australia, Australia


AWARDS/GRANTS

South Australian Health and Medical Research Institute Research Bursary (2011–2013): Tuition support for CRTP



PUBLISHED MANUSCRIPTS AND BOOK CHAPTERS

FROM JULY, 2012–JUNE, 2013

1 Ahmad T, Felker GM. ACP Journal Club: Warfarin and Aspirin did not differ for death or stroke in heart failure and sinus rhythm. Ann Intern Med. Oct 2012

2 Ahmad T, Felker GM. Galectin-3 Levels in Heart Failure: More Answers or More Questions? J Am Heart Assoc. 2012 Oct;1(5).

3 Ahmad T, Felker GM. Subcutaneous BNP for Treatment of Heart Failure: A Dying Therapy Reborn? J Am Coll Cardiol. 2012 Dec 4;60(22):2313–5.

4 Ahmad T, Patel CB, Milano CA, Rogers, JG. When the heart runs of out heartbeats: treatment options for refractory end-stage heart failure. Circulation. 2012 Jun 12;125(23):2948–55.

5 Al-Khatib SM, Mi X, Wilkoff BL, Qualls LG, Frazier-Mills C, Setoguchi S, Hess PL, Curtis LH. Follow-up of Patients With New Cardiovascular Implantable Electronic Devices: Are Experts’ Recommendations Implemented in Routine Clinical Practice? Circ Arrhythm Electrophysiol 6(1): 108–16.

6 Anderson M, Peterson ED, Brennan JM, Rao S, Dai D, Anstrom K, Piana R, Popescu A, Sedrakyan A, Messenger JC, Douglas PS. Acute and Long-term Outcomes of Coronary Stenting in Women vs. Men: Results from the National Cardiovascular Data Registry® Centers for Medicare & Medicaid Services® Cohort, Circulation. 2012; 126: 2190–219.

7 Autmizguine J, Krajinovic M, Rousseau J, Théorêt Y, Litalien C, Marquis C, Tapiéro B, Ovetchkine P. Pharmacogenetics and beyond: variability of voriconazole plasma levels in a patient with primary immunodeficiency. Pharmacogenomics 2012; 13(16): 1961–1965.

8 Bagai A, Cantor WJ, Tan M, Tong W, Lamy A, Fitchett D, Cohen EA, Mehta SR, Borgundvaag B, Ducas J, Heffernan M, Dzavik V, Morrison L, Schwartz B, Lazzam C, Langer A, Goodman SG. Early and Late Outcomes and Cost Implications of Routine Early PCI after Fibrinolysis. Am Heart J. 2013 Apr:165(4):630–637.

9 Bagai A, Chen AY, Wang TY, Alexander KP, Ohman ME, Hochman JS, Peterson ED, Roe, MD. Long-term Outcomes Among Elderly Patients With Non-ST-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. Am Heart J. 2013 Aug; 166(2): 298–305.

10 Bagai A, Granger CB. Acute coronary syndromes: Streamlining care for patients with STEMI. Nature reviews. Cardiology, 2013.

11 Bagai A, Granger CB. Regionalization of ST-segment elevation myocardial infarction care: A task unfinished. Am Heart J. 2012 Nov: 164(5):633–5.

12 Bagai A, Jollis JG, Dauerman HL, Peng SA, Rokos IC, Bates ER, French WJ, Granger CB, Roe MT. Emergency Department Bypass for ST-Segment Elevation Myocardial Infarction Patients Identified with a Pre-hospital Electrocardiogram: A Report From the American Heart Association Mission: LifelineTM Program. Circulation. 2013 Jul 23;1 28(4):352–9.

13 Bagai A, O’Brien S, Al Lawati H, Goyal P, Ball W, Grantcharov T, Fam, N. Mentored Simulation Training Improves Procedural Skills in Cardiac Catheterization: A Randomized, Controlled Study. Circ Cardiovasc Int. 2012 Oct 1:5(5):672–9.

14 Beijk MA, Harskamp RE. Treatment of Coronary Artery Bypass Graft Failure. Artery Bypass, InTech, 2013.

15 Bernacki, GM; Becker R. Oral Anticoagulants in Older Adults with Atrial Fibrillation. J Thromb Thrombolysis. E-publication ahead of print: January 23, 2013, DOI 10.1007/s11239-013-0869-0.

16 Bernacki, GM; Fosbol, E; Dai, D; Peterson, E; Alexander, KP. Greater Use and Better Outcomes Following Cardiac Surgery in Octogenarians: 19-Year (1991–2009) Trends from the Medicare Population. J Am Coll Cardiol. 2013; 61(10_S). doi:10.1016/S0735-1097(13)61600–9.

17 Cohen-Wolkowiez M, Sampson M, Bloom B, Arrieta A, Wynn J, Martz K, et al. Determining Population and Developmental Pharmacokinetics of Metronidazole Using Plasma and Dried Blood Spot Samples from Premature Infants. Pediatr Infect Dis J. 2013 [Epub ahead of print]

18 Damman P, Kampinga MA, van der Horst IC, Woudstra P, Grundeken MJ, Kuijt WJ, Harskamp RE, Nijsten MW, Zijlstra F, Tijssen JG, de Smet BJ, de Winter RJ. Multiple biomarkers for the prediction of short and long-term mortality after ST-segment elevation myocardial infarction: the Amsterdam-Groningen collaboration. J Thromb Trombolysis. 2013; 36:42–6.

19 Damman P, Woudstra P, Kuijt WJ, Kikkert WJ, van de Hoef TP, Grundeken MJ, Harskamp RE, Henriques JP, Piek JJ, Tijssen JG, de Winter RJ. Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Interv Cardiol 2013; 26:8–13.

20 de Souza Brito F, Lopes RD, Alexander JH.: The safety and efficacy of apixaban: where do we stand in 2013? Expert Opin Drug Saf. 2013 Jul; 12(4):559–67.

21 de Souza Brito F, Tricoci P.: Novel anti-platelet agents: focus on thrombin receptor antagonists. J Cardiovasc Transl Res. 2013; 6(3):415–24.

22 Dinan MA, Carpenter WR, Patz EF Jr, Abernethy AP, Biddle AK, Schulman KA, Curtis LH. Reply to M.S. Hofman et al. J Clin Oncol. 2013 Feb 20; 31(6):820.

23 Dinan, MA, Curtis, LH, Carpenter, WR, Biddle AK, Abernethy, AP, Patz, EF, Schulman, KA, Weinberger, M. Variations in the Use of Positron Emission Tomography Among Medicare Beneficiaries With Non-Small-Cell Lung Cancer, 1998–2007. Radiology 2013 Jun; 267(3):807–17. Epub 2013 Feb 15.

24 Dinan, MA. Observational Research. Understanding Clinical Research. The McGraw-Hill Company, Inc. 2013.

25 Englum BR, Andersen ND, Husain AM, Mathew JP, Hughes GC. Degree of hypothermia in aortic arch surgery — optimal temperature for cerebral and spinal protection: deep hypothermia remains the gold standard in the absence of randomized data. Ann Cardiothorac Surg 2013;2(2):184–193.

26 Englum BR, Hopkins MB, Miglay J. Technical Challenges: Reoperative Surgery in Ross H, Lee S, Mutch M, et al. (eds): Minimally Invasive Approaches to Colon and Rectal Disease: Techniques and Best Practices. Springer Business Media, 2013.

27 Gardner CS, Patil AS, Miller CM, James AH, Jaffe TA. Cancer in pregnancy: oncologic imaging utilization at a tertiary care center with an algorithmic approach to imaging. Clinical Imaging. 2012 Nov–Dec; 36(6):780–90.

28 Grundeken MJ, Smits M, Harskamp RE, Damman P, Woudstra P, Hoorweg AJ, Baan J Jr, Arkenbout EK, Piek JJ, Vis MM, Henriques JP, Koch KT, Tijssen JG, de Winter RJ, Wykrzykowska JJ. Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions. Neth Heart J 2013;20: 439–46.

29 Gunatilake R, Patil A. Drugs in pregnancy. The Merck manual [Internet]. Whitehouse Station (NJ): Merch Sharp & Dohme Corp; c2010–2013; [cited 2013 Feb 26].

30 Halim SA, Kiefer TL, Hughes GC, Hurwitz LM, Harrison JK. Transcatheter aortic valve replacement: an update. Curr Cardiol Rep. 2013 Jun;15(6):367.

31 Halim SA, Newby LK. ACP Journal Club. Review: Omega-3 fatty acid supplements provide no protective benefit in cardiovascular disease. Ann Intern Med 2012 Aug 21;157(4):JC2–3.

32 Hall RK, O’Hare AM, Anderson RA, Colón-Emeric CS, “End stage renal disease in Nursing Homes: A Systematic Review”. J Am Med Dir Assoc. 2013; 14(4):242–7.

33 Hall RK, Wang VW, Jackson GL, Hammill BG, Maciejewski, ML, Yano EM, Svetkey, LP, Patel UD, “Implementation of Automated Reporting of Estimated Glomerular Filtration Rate among Veterans Affairs Laboratories: a retrospective study”, BMC Med Inform Decis Mak. 2012;12:69.

34 Harrison RW, Aggarwal A, Ou FS, et al. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. Jan 15 2013; 111(2):178–184.

35 Harrison RW, Rao SV. Rationale for Transradial Access. In: Cohen HA, ed. Transradial Access: Techniques for Diagnostic Angiography and Percutaneous Intervention. Minneapolis, Minnesota: Cardiotext Publishing; 2013.

36 Harskamp RE, Beijk MA, Damman P, Kuijt WJ, Woudstra P, Grundeken MJ, Kloek JJ, Tijssen JG, de Mol BA, de Winter RJ. Clinical Outcome after surgical and percutaneous revascularization in coronary bypass graft failure. J Cardiovasc Med 2013; 14:438–445.

37 Harskamp RE, Beijk MA, Damman P, Tijssen JG, Lopes RD, de Winter RJ. Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention. Am J Cardiol. 2013; 111(2): 153–8.

38 Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013; 257(5): 824–33.

39 Harskamp RE, Park DW. Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease. Cardiol Ther 2013; 2:69–84.

40 Harskamp RE, Park DW. Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced? Expert Rev Cardiovasc Ther. 2013; 11(5): 541–53.

41 Harskamp RE, Williams JB, Hill RC, de Winter RJ, Alexander JH, Lopes RD. Saphenous vein graft failure and clinical outcomes: Toward a surrogate end point in patients following coronary artery bypass surgery? Am Heart J 2013; 165(5): 639–43.

42 Havrilesky, LJ, Moorman, PG, Lowery, WJ, Gierisch, JM, Coeytaux, RR, Urrutia, RP, Dinan, MA, McBroom, AJ, Hasselblad, V, Sanders, GD, Myers, ER. Oral Contraceptive Pills as Primary Prevention for Ovarian Cancer: A Systematic Review and Meta-analysis. Obstet Gynecol. 2013 Jul;122(1):139–147.

43 Hess CN, Becker RC, Alexander JH, Lopes RD. Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician. J Thromb Thrombolysis 2012; 34:552–61.

44 Hess CN, Broderick S, Piccini JP, Alexander KP, Newby LK, Shaw LK, Mahaffey KW, Alexander JH, Peterson ED, Granger CB, Lopes RD. Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. Am Heart J 2012; 164:607–15.

45 Hess CN, Rao SV, Kong DF, Miller JM, Anstrom KJ, Bertrand OF, Collet JP, Effron MB, Eloff BC, Fadiran EO, Farb A, Gilchrist IC, Holmes DR, Jacobs AK, Kaul P, Newby LK, Rutledge DR, Tavris DR, Tsai TT, White RM, Peterson ED, Krucoff MW. TransRadial Education And Therapeutics (TREAT): Shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a Report from the Cardiac Safety Research Consortium. Am Heart J 2013 Mar; 165:344–53.

46 Hess CN, Rao SV, Skelding K, Kern MJ, Krucoff MW. Arterial and Venous Access and Hemostasis for PCI. The Interventional Cardiac Catheterization Handbook, 3rd ed. Ed. Morton J. Kern. Philadelphia: Elsevier, 2012.

47 Hess CN, Schulte PJ, Newby LK, Steg PG, Dalby AJ, Schweiger JM, Lesiw BS, Armstrong PW, Califf RM, Van de Werf F, Harrington RA. Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS. Eur Heart J Acute Cardiovasc Care, 2013 Sept; 2(3): 246–255.

48 Hess PL,Grau-Sepulveda M, Hernandez AF, Peterson ED, Bhatt DL, Schwamm LH, Yancy CW, Fonarow GC, M.D., Al-Khatib SM. Age Differences in the Use of Implantable Cardioverter-Defibrillators Among Older Patients Hospitalized With Heart Failure. J Cardiovasc Electrophysiol 24 (6): 664–671.

49 Hess PL, Jackson KP, Hasselblad V, Al-Khatib SM. Is Cardiac Resynchronization Therapy an Antiarrhythmic Therapy for Atrial Fibrillation? A Systematic Review and Meta-Analysis. Curr Cardiol Rep; 15 (330): 1–7.

50 Hess PL, Kim, S, Piccini JP, Allen LA, Ansell JE, Chang P, Freeman JV, Gersh BJ, Kowey, Mahaffey KW, Thomas L, Peterson ED, MD, Fonarow GC. Use of Evidence-Based Primary and Secondary Cardiac Prevention Therapy Among Outpatients with Atrial Fibrillation. Am J Med 126 (7): 625–632.

51 Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Al-Khatib SM, Piccini JP, Inoue LYT, Sanders GD. Survival Benefit of Primary Prevention Implantable Cardioverter-Defibrillator Therapy After Myocardial Infarction: Does Time to Implant Matter? A Meta-Analysis Using Patient-Level Data from 4 Clinical Trials. Heart Rhythm 10 (6): 828–835.

52 Hess PL, Mi X, Curtis LH, Wilkoff BL, Hegland D, Al-Khatib SM. Follow-up of Patients With New Cardiovascular Implantable Electronic Devices: Is Adherence to the Experts’ Recommendations Associated With Improved Outcomes? Heart Rhythm Epub Jun 14, 2013.

53 Koshizaka M, Green JB, Alexander JH. Glycemic management in diabetes and the associated cardiovascular risk — Are we helping or hurting our patients? Circ J. 2012;76(7):1572–80.

54 O’Brien EC, Rose KM, Suchindran CM, Stürmer T, Chang PP, Alonso A, Baggett CD, Rosamond WD. Temporal trends in medical therapies for ST- and Non-ST Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study. Am J Cardiol 2013;111:305–311.

55 O’Brien EC, Rose KM, Suchindran CM, Stürmer T, Chang PP, Guild CS, Chambless LE, Rosamond WD. Medication and reperfusion therapy and survival in a community-based setting of hospitalized myocardial infarction: The Atherosclerosis Risk in Communities (ARIC) Surveillance Study. Heart 2013: 1–7.

56 O’Connor C, Ahmad T. Can Exercise Prevent Heart Failure? J Am Coll Cardiol. 2012 Dec 18; 60(24): 2548–9.

57 Patel PA, Hernandez AF. Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy. Eur J Heart Fail. 2013 Jul; 15(7):724–9.

58 Patil AS, Dotters-Katz SK, Metjian AD, James AH, Swamy GK. Use of a Thrombopoietin Mimetic for Chronic Immune Thrombocytopenic Purpura in Pregnancy. Obstet Gynecol. 2013 Aug; 122(2, Part 2): 1–3.

59 Pearce RE, Cohen-Wolkowiez M, Sampson MR, Kearns GL. The Role of Human Cytochrome P450 Enzymes in the Formation of 2-Hydroxymetronidazole: CYP2A6 is the High Affinity Catalyst. Drug Metab Dispos. 2013 [Epub ahead of print]

60 Reed SD, Dinan MA, Schulman KA, Lyman GH. Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer. Genet Med. 2013 Mar; 15(3):203–11.

61 Sampson MR, Cohen-Wolkowiez M, Capparelli EV, Watt KM. Pharmacokinetics of Antimicrobials in Obese Children. GaBi J. 2013 [Epub ahead of print]

62 Shah RS, Holmes D, Anderson M, Wang TY, Kontos MC, Wivott SD, Scirica BM. Risk of heart failure complication during hospitalization for acute myocardial infarction in a contemporary population: insights from the National Cardiovascular Data ACTION Registry. Circ Heart Fail. 2012 Nov;5(6):693–702.

63 Sherwood MW, Piccini JP. Randomised controlled trial: For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding. Evid Based Med. 2012 Oct;17(5):148–9.

64 Sherwood, MW, Rao, SV. Acute coronary syndromes: Blood transfusion in patients with acute MI and anaemia. Nat Rev Cardiol. 2013 Apr; 10(4):186–7.

65 Sherwood MW, Rao SV. What are the Best ways to predict and prevent bleeding in the setting of Pharmacologic therapies for Acute Coronary Syndromes? Curbside Consultation in Cardiology. SLACK incorporated; Healio Books. February 2013

66 Steinberg BA, Daubert JP. Dose-Adjusted Warfarin: Writing the Prescription is Only the Beginning. J Electrocardiol. 2012 Nov 28. pii: S0022-0736(12)00473–6.

67 Steinberg BA, Harrison JK, Hughes GC, Piccini JP. Electrophysiologic Considerations of Transcatheter Aortic Valve Replacement. Am Heart J. 2012; 164:664–71.

68 Steinberg BA, Holmes DJN, Ezekowitz MD, Fonarow GC, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, Chang P, Peterson ED, Piccini JP, on behalf of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients. Rate versus Rhythm Control for Management of Atrial Fibrillation in Clinical Practice: Results from the ORBIT-AF Registry. Am Heart J. 2013; 165:622–9.

69 Steinberg BA, Jollis JG, Winkler A, Granger C, Newby LK. Treatment Pathways and Quality Improvement for Patients with Acute Myocardial Infarction at a Tertiary Care Center. Crit Pathw Cardiol, 2012; 11:77–80.

70 Steinberg BA, Piccini JP. Left Atrial Remodeling: Shape Before Size? J Cardiovasc Electrophysiol. 2013 Mar 8. doi: 10.1111/jce.12132. [Epub ahead of print].

71 Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC. Trends in Patients Hospitalized with Heart Failure and Preserved Left Ventricular Ejection Fraction — Prevalence, Therapies, and Outcomes. Circulation. 2012; 126:65–75.

72 Testoni D, Hornik CP, Smith PB, Benjamin Jr. DK, McKinney Jr. RE, Sports Medicine and Ethics, Am J Bioeth, April 2013.

73 Testoni D, Smith PB, Benjamin DK Jr. The Use of Antifungal Therapy in Neonatal Intensive Care, Clin Perinatol, March 2012; 39(1): 83–98.

74 Tracy ET, Englum BR, Barbas AS, Foley C, Rice HE, Shapiro ML. Pediatric injury patterns by year of age. J Pediatr Surg. 2013 June; 48(6): 1384–1388.

75 Tsuang WM, Vock DM, Finlen Copeland CA, Lederer DJ, Palmer SM. An acute change in lung allocation score and survival after lung transplantation: a cohort study. Ann Intern Med. 2013 May 7;158(9):650–7.

76 Virkud YV, Vickery BP. Advances in immunotherapy for food allergy. Discov Med 2012; 14(76):159–65.

77 Wong YW, Felker GM. Etiology and overview of heart failure. In Krum H, von Lueder T, Advances in Heart Failure Management (6-17). Future Medicine, 2012.

78 Wong YW, Schulman K. Ethics in Clinical Research: An overview and emerging issues. In Lopes RD, Harrington RA, Understanding Clinical Research (39-64). McGraw-Hill Companies, Inc., 2013.

79 Wong YW, Thomas L, Sun JL, McMurray JJ, Krum H, Hernandez AF, Rutten GE, Leiter LA, Standl E, Haffner SM, Mazzone T, Martinez FA, Tognoni G, Giles T, Califf RM. Predictors of Incident Heart Failure Hospitalizations among Patients with Impaired Glucose Tolerance: Insight from the NAVIGATOR Study. Circ Heart Fail. 2013 Feb 6.

80 Woudstra P, Damman P, Beijk MA, Grundeken MJ, Harskamp RE, Koch KT, Henriques JP, Baan J Jr, Vis MM, Piek JJ, Tijssen JG, de Winter RJ. Clinical outcomes after bare-metal stenting diabetic patients with lesions carrying a low risk of restenosis. Catheter Cardiovasc Interv 2013; 8:26–33.

MANUSCRIPTS AND BOOK CHAPTERS ACCEPTED FOR PUBLICATION

1 Ahmad T, O’Connor C. Using Biomarkers to Guide Therapy in Heart Failure. Clin Pharmacol Ther. In press.

2 Autmizguine J, Watt KM, Théorêt Y, Kassir N, Laferrière C, Parent S, Tapiero B, Ovetchkine P. Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infections. Pediatr Infect Dis J. In press.

3 Bagai A, Al-Khalidi H, Muñoz D, Monk L, Roettig ML, Granger CB, Jollis, JG. Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-Hospital ST-Segment Elevation: Findings from the Reperfusion of Acute Myocardial Infarction in Carolina Emergency Departments (RACE) Project. Circ Cardiovasc Interv. In press.

4 Bagai A, White JA, Lokhnygina Y, Guigliano RP, Van de Werf F, Montalescot G, Armstrong PW, Tricoci P, Gibson CM, Califf RM, Harrington RA, Newby LK. Routine Early Eptifibatide versus Delayed, Provisional Use at Percutaneous Coronary Intervention in High-Risk Non-ST-Segment Elevation Acute Coronary Syndrome Patients: An Analysis from the Early ACS Trial. Am Heart J. In press.

5 Bernacki, GM; Alexander KA. Aortic Stenosis in Long Term Care. Ann Longterm Care. In press.

6 Corotto PS, McCarey MM, Adams S, Khazanie P, Whellan DJ. Heart failure patient adherence: epidemiology, cause, and treatment, Heart Fail Clin. In press.

7 de Souza Brito F, Lopes RD, Roe MT. Coronary Artery Disease. Chapter 2 in Atherothrombosis in Clinical Practice: Oxford American Cardiology Library, 2013. In press.

8 de Souza Brito F, Tricoci P. Chapter: Thrombin receptor antagonists in Antiplatelet Therapy: Wiley Company. In press.

9 Felker GM, Ahmad T. Natriuretic Peptides and Primary Prevention: The New World? J Am Heart Assoc. In press.

10 Felker GM, Fiuzat M, Thompson V, Shaw L, Adams K, Whellan D, Donahue M, Ahmad T, Kitzman D, Pina I, Zannad F, Kraus W, O’Connor C. Soluble ST2 in Ambulatory Patients with Heart Failure: Association with Functional Capacity and Long-Term Outcomes. Circ Heart Fail. In press.

11 Folzer E, Gonzalez D, Singh R, Derendorf H. Comparison of skin permeability for three diclofenac topical formulations: An in vitro study. Pharmazie 2013. In press.

12 Gierisch J, Coeytaux R, Peragallo Urrutia RR, Havrilesky L, Moorman P, Lowery WJ , Dinan MA, McBroom A, Hasselblad V, Sanders G, and Myers E. Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review. Cancer Epidemiol Biomarkers Prev. In press.

13 Haddad F, Khazanie P, Deuse T, Weisshaar D, Zhou J, Nam CW, Vu TA, Gomari FA, Skhiri M, Schnittger I, Vrotvec B, Hunt SA, Fearon WF. Clinical and functional correlates of early microvascular dysfunction following heart transplantation. Circ Heart Fail. In press.

14 Harrison RW, Hasselblad V, Mehta RJ, Levin R, Harrington RA, Alexander JH. Effect of Levosimendan on survival and adverse events after cardiac surgery: a meta-analysis. J Cardiothorac Vasc Anesth. In press.

15 Hess CN, Rao SV, Kong DF, Aberle LH, Anstrom KJ, Gibson CM, Gilchrist IC, Jacobs AK, Jolly SS, Messenger JC, Newby LK, Waksman R, Krucoff MW. Embedding a Randomized Clinical Trial into an Ongoing Registry Infrastructure: Unique Opportunities for Efficiency in Design of the Study of Access site For Enhancement of PCI for Women (SAFE-PCI for Women). Am Heart J. In press

16 Khazanie P, Granger CB. A 10-year exercise program improved oxygen consumption and quality of life in stable chronic heart failure, Ann Intern Med. In press.

17 Khazanie P, Newby LK. In patients with heart failure, beta-blockers reduce mortality but do not differ from each other, Ann Intern Med. In press.

18 Peragallo Urrutia R, Coeytaux RR, McBroom AJ, Gierisch JM, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan MA, Hasselblad V, Sanders GD, Myers ER. Risk of Acute Thromboembolic Events With Oral Contraceptive Use: A Systematic Review and Meta-Analysis. Obstet Gynecol. In press.

19 Piccini JP, Zhao Y, Steinberg BA, Mathew JP, Fullerton D, Hegland DD, Hernandez AF, Mills RM, Klaskala W, Peterson ED. Atrial Fibrillation following Cardiac Surgery: Comparative Effectiveness of Preoperative Prophylaxis. Am J Caridol. In press.

20 Pokorney S, Sherwood MW, Becker RC. Clinical Strategies for Selecting Oral Anticoagulants in Patients with Atrial Fibrillation. J Thrombosis and Thrombolysis. In press.

21 Rao SV, Hess CN, Dai D, Green CL, Peterson ED, Douglas PS. Temporal Trends in Percutaneous Coronary Intervention Outcomes in the United States. Am Heart J. In press

22 Sherwood MW, Rao SV. Vascular Access, Closure, and Management. Chapter In Textbook of Cardiovascular Intervention. Editor Craig Thompson. Springer Publications. New York, NY. In press.

23 Steinberg BA, Beckley P, Deering TF, Clark CL, Amin AN, Bauer KA, Cryer B, Mansour M, Scheiman JM, Zenati MA, Newby LK, Peacock WF, Bhatt DL, for the Society of Cardiovascular Patient Care. Evaluation and Management of the Atrial Fibrillation Patient: A Report from the Society of Cardiovascular Patient Care. Crit Pathw Cardiol. In press.

24 Steinberg BA, Hasselblad V, Atwater BD, Bahnson TD, Washam JB, Alexander JH, Daubert JP, Piccini JP. Dabigatran for Periprocedural Anticoagulation Following Radiofrequency Ablation for Atrial Fibrillation: A Meta-Analysis of Observational Studies. J Interv Card Electrophysiol. In press.

25 Steinberg BA, Kim S, Piccini JP, Fonarow GC, Lopes RD, Thomas L, Ezekowitz MD, Ansell J, Kowey P, Singer DE, Gersh B, Mahaffey KW, Hylek E, Go AS, Chang P, Peterson ED. Use and Associated Risks of Concomitant Aspirin Therapy with Oral Anticoagulation in Patients with Atrial Fibrillation: Insights from the ORBIT-AF Registry. Circulation. In press.

26 Virkud, Y. Encyclopedia of Medical Immunology. Ian R. Mackay and Noel R. Rose. Chapter — Delayed Anaphylaxis to Mammalian Meat (Alpha-Gal), Vol 1. In press.

27 Wong YW, Mi XJ, Fonarow GC, Peacock WF IV, Mills RM, Curtis LH, Qualls LG, Hernandez AF. Early Intravenous Heart Failure Therapy and Outcomes among Older Patients Hospitalized for Acute Decompensated Heart Failure: Analysis of ADHERE Registry Emergency Module. Am Heart J. In press.

ABSTRACTS PRESENTED

1 Ahmad T. A Cacophany of Wedges, Which One Tells the Truth? Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

2 Ahmad T, Felker GM, Fiuzat M, Thompson V, Shaw L, Adams K, Whellan D, Donahue M, Kitzman D, Pina I, Zannad F, Kraus W, O’Connor CM. Interaction between ST2 Levels and Exercise Training in Patients with Chronic Heart Failure: Analysis from the HF-ACTION Trial. Scientific Sessions of the American College of Cardiology, Chicago, IL. March 24–27, 2012.

3 Ahmad T, Fiuzat M, Neely B, Neely M, Adams K, Whellan D, Donahue M, Kitzman D, Pina I, Zannad F, Kraus W, O’Connor CM, Felker GM Relationship Between Exercise Training and Changes in Biomarkers of Myocardial Stress, Injury and Inflammation in Patients with Chronic Heart Failure. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

4 Ahmad T, Fiuzat M, Stevens S, Adams KF, Piña IL, Zannad F, Kitzman DW, Kraus WE, O’Connor CM, Felker GM. Elevated Galectin-3 Levels and Prediction of Mode of Death in Heart Failure: Insights from the HF-ACTION Study. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

5 Anderson M, Cox M, Al-khatib SM, Thomas KL, Fosbol EL, Chan PS, Nichol G, Peterson MD. Cardiopulmonary Resuscitation (CPR) Training Rates in the United States. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

6 Anderson, M, Jollis JG, Peterson ED, Lopes RD, Blanco RG, Fraulo E, Pathman J, Moore A, Short L, Granger CG. Cardiac Arrest and Cardiopulmonary Resuscitation Knowledge at an Academic Research Organization in Durham, North Carolina. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

7 Autmizguine J, Watt K, Kassir N, Théorêt Y, Watt K, Parent S, Tapiéro B, Ovetchkine P. Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infection. Infectious Disease Week Annual Meeting, San Diego, CA. October 17–21, 2012.

8 Bagai A, Al-Khalidi H, Muñoz D, Monk L, Roettig ML, Granger CB, Jollis JG. Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-Hospital ST-Segment Elevation: Findings from the Reperfusion of Acute Myocardial Infarction in Carolina Emergency Departments (RACE) Project. Transcatheter Therapeutics Scientific Sessions, Miami, FL. October 22–26, 2012.

9 Bagai A, Jollis JG, Dauerman HL, Peng SA, Bates ER, French WJ, Granger CB, Roe MT. Bypassing the Emergency Department is Associated with Faster Reperfusion in Patients with Pre-Hospital ST-Segment Elevation: Findings from the ACTION Registry ®- GWTG™. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

10 Bagai A, McNally B, Myers BJ, Kim S, van Diepan S, Fosbol EL, Monk L, Abella BS, Granger CB, Jollis JG. Survival with Out-Of-Hospital Cardiac Arrest is Lowest at Night: Findings from the Cardiac Arrest Registry to Enhance Survival (CARES). Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

11 Bagai A, Parthasarathy H, Fallis B, Fosbol EL, Al-Shehri M, Cheema AN, Kutryk M, Buller C, Chisholm R, Fam N, Graham JG. Repatriation to non-PCI center after Primary PCI for STEMI: Insights of a Regionalized STEMI Care System. Canadian Cardiovascular Congress Scientific Sessions, Toronto, Canada. October 27–31, 2012.

12 Bagai A, Peterson ED, Honeycutt E, Effron MB, Cohen DJ, Goodman SG, Anstrom K, Messenger JC, Wang TY. In-hospital Switching of ADP Receptor Inhibitors in Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

13 Jesse Bain DO, David A Turner MD, Kyle J Rehder MD, P. Brian Smith MD, R. Duane Davis MD, Ira M Cheifetz MD, David Zaas MD. Ambulatory ECMO as a Bridge to Lung Transplantation is More Cost Effective Than a Non-ambulatory Strategy” Poster presentation, Society of Critical Care Medicine, 42nd Annual Congress, San Juan, Puerto Rico. January 19–23, 2013.

14 Bernacki, GM; Alexander, KP; Lopes, RD; Roe, MT; Li, S; Thomas, LE; Peterson, ED; Shah BR. Clinical Factors Associated with Multiple Readmissions after Non-ST-Elevation Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2013; 6:A169.

15 Dinan MA, Curtis LH, Setoguchi Iwata S, Cheung W. Association between High Cost Imaging and Hospice Use at the End of Life of Cancer Patients. American Society of Clinical Oncology Annual Meeting, Chicago, IL, 2013.

16 Dinan MA, Curtis LH, Setoguchi Iwata S, Cheung W. Association between High Cost Imaging and Hospice Use at the End of Life of Cancer Patients. Duke Cancer Institute Annual Scientific Research Conference, Durham, NC. 2013.

17 Dinan MA, Havrilesky LJ, Myers ER, Curtis LH. Geographic Distribution of Oophorectomies performed for ovarian cancer and the availability of Gynecologic Oncologists in the United States. AcademyHealth Annual Meeting, Baltimore MD June 23–25, 2013.

18 Dinan MA, Li Y, Zhang Y, Stewart SB, George DJ, Reed SD. Resource use in the Last Year of Life among Medicare Beneficiaries who died from versus with Prostate Cancer between 2000 and 2007. American Society of Clinical Oncology Annual Meeting, Chicago, IL. May 31–June 4, 2013.

19 Hall RK, O’Hare AM, Anderson RA, Colon-Emeric CS. End stage renal disease in Nursing Homes: A Systematic Review. American Medical Directors Association Long Term Care Medicine Conference, Washington, DC. March 21–24, 2013.

20 Hall RK, O’Hare AM, Anderson RA, Colon-Emeric CS. End stage renal disease in Nursing Homes: A Systematic Review. Claude D. Pepper Older Americans Independence Center Annual Meeting, 2013.

21 Hall RK, O’Hare AM, Anderson RA, Colon-Emeric CS. End stage renal disease in Nursing Homes: A Systematic Review. Southern Society for Clinical Investigation Nephrology Young Investigators’ Forum, New Orleans, LA. Feburary 20, 2013.

22 Harrison RW, Dai D, Roe MT, Messenger JC, Anderson V, Peterson ED, Wang TY. Longitudinal Outcomes of Bare Metal Stent Placement Before and After the FDA Drug Eluting Stent Advisory: a Report from the Linked CathPCI Registry-CMS Claims Database. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

23 Harrison RW, Miller AL, Holmes D, de Lemos JA, Peterson ED, Wang TY. Association of Hospital Myocardial Infarction Volume with Adherence to ACC/AHA Performance Measures: Insights from NCDR®. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

24 Harrison RW, White K, Domanski MJ, Brener SJ, Smith PK, Hillis GS, Engoren M, Alexander JH, Levy JH, Chaitman BR, Mack MJ, Farkouh ME, Mahaffey KW. Frequency and prognostic importance of troponin and CK-MB elevations following CABG: An analysis from PRIMO I and PRIMO II. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

25 Harrison RW, Wojdyla D, Mahaffey KW. Lost to follow-up in contemporary global cardiovascular randomized clinical trials. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

26 Harskamp RE, Alexander JH, Schulte P, Jones S, Williams J, Mack M, Peterson E, Gibdson CM, Califf RM, Kouchoukos N, Ferguson TB, De Winter RJ, Lopes RD. Extra-cardiac vascular disease is associated with worse five-year clinical outcomes but not with vein graft failure after coronary artery bypass graft surgery: insights from the PREVENT-IV trial. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

27 Harskamp RE, Wang T, Bhatt D, Wiviott S, Amsterdam E, Li S, Thomas L, de Winter RJ, Roe MT. Variation in the hospital-level use of a medical management strategy across US hospitals for patients with NSTEMI and multivessel coronary artery disease detected during in-hospital angiography. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

28 Hess CN, Peterson ED, Dai D, Neely ML, Piana R, Hillegass W, Kutcher M, Messenger JC, Pancholy S, Rao SV. Relationship Between Transradial Percutaneous Coronary Intervention Experience and Procedural Metrics. Oral presentation at Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

29 Hess CN, Rao SV, Dai D, Neely ML, Piana R, Messenger JC, Peterson ED. Predicting Target-Vessel Revascularization among Older Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era. Poster presentation at Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

30 Hess CN, Shah BR, Peng SA, Thomas L, Roe MT, Peterson ED. Relationship of Early Physician Follow-up and 30-Day Readmission Among Older NSTEMI Patients. Oral presentation at Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

31 Hess CN, Wang TY, Kaltenbach L, Honeycutt E, Messenger JC, Smith WT, Zettler ME, Effron MB, Henry TD, Peterson ED, Fonarow GC. Unplanned 30-Day Readmission Risk Among Patients with Acute Myocardial Infarction: a Report from TRANSLATE-ACS. Poster presentation at Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

32 Hess PL, Shaw LK, Shepherd ML, MacKenzie M, Pagnanelli R, Fiuzat M, Piccini JP, Al-Khatib SM, O’Connor CM, Borges-Neto S. Mechanical Dyssynchrony Defined by Phase Analysis from GSPECT: Does it Predict Mortality? Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

33 Hess PL, Tricoci P, Horton J, Lokhnygina Y, Al-Khatib S, Piccini J, Harrington R, Armstrong P, Aylward P, Moliterno D, Van de Werf F, Wallentin L, White H, Held C, Mahaffey K. Incidence and Predictors of Sudden Cardiac Death after Hospitalization for Non-ST-Segment Elevation Myocardial Infarction: An Analysis from the TRACER trial. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

34 Khazanie P, Hammill BG, Eapen ZJ, Curtis LH, Hernandez AF. Trends and Outcomes in Mechanical Circulatory Support Among Medicare Beneficiaries. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

35 Khazanie P, Liang L, Qualls LG, Curtis LH, Fonarow GC, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Hernandez AF, Piccini JP. Outcomes of Medicare Beneficiaries With Heart Failure and Atrial Fibrillation. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

36 Mukerjee R, Coeytaux R, Hall R, Reams D, Schell J, Thompson C, Tyson C, Wang V, Bosworth H, Svetkey L, Patel U. Effects of multidisciplinary care on outcomes in chronic kidney disease: a systematic review and meta-analysis. Oral presentation at the American Society of Nephrology Kidney Week, San Diego, CA. October 30–November 4, 2012.

37 Mukerjee R, Coeytaux RR, Hall RK, Reams D, Schell JO, Tyson CC, Wang VW, Bosworth H, Svetkey LP, Patel UD. Effects of Multidisciplinary Care on Outcomes in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. American Society of Nephrology Annual Kidney Week, San Diego, CA. October 30–November 4, 2012.

38 O’Brien EC, Fosbol E, Peng SA, Alexander KP, Roe MT, Peterson ED. The Obesity Paradox: Implications for Long-term Outcomes in Non-ST-Elevation Myocardial Infarction. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

39 O’Brien EC, Holmes DJ, Koller C, Peterson ED, Piccini J. Contraindications to Oral Anticoagulation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Poster presentation at the 2013 AHA Quality of Care and Outcomes Research Conference; Baltimore, MD. May 15–17, 2013.

40 O’Brien EC, Holmes DJ, Piccini J, Peterson ED. Reasons for Warfarin Discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Oral presentation at the 2013 AHA Quality of Care and Outcomes Research Conference; Baltimore, MD. May 15–17, 2013.

41 Patel PA, Buckner C, Delana K, Niemchak S, Setji N, Spurney Y, Stillwagon MJ, Velazquez M, Wright S, Bae J. Patient Satisfaction & Self-Assessed Discharge Readiness Correlates with Readmission. Society of Hospital Medicine and Duke Patient Safety Conference, 2013.

42 Patel PA, Heizer G, Schulte P, O’Connor CM, Dickstein K, Ezekowitz JA, Hasselblad V, Massie BM, Mills RM, McMurray JJ, Starling RC, Tang WH, Califf RM, Hernandez AF. Hypotension in Acute Decompensated Heart Failure: Findings from ASCEND-HF. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

43 Patel PA, Zhao X, Fonarow GC, Lytle BL, Smith EE, Xian Y, Bhatt DL, Peterson ED, Schwamm LH, Hernandez AF. Use of Novel Anticoagulants among Atrial Fibrillation Patients Hospitalized with Ischemic Stroke or Transient Ischemic Attack: A Get With The Guidelines-Stroke Registry Analysis. American Heart Association Quality of Care and Outcomes Research Annual Conference, 2013.

44 Patil AS, Grotegut C, Dotters-Katz SK, Swamy G, Murtha AP, James AH. Predictive Modeling of Anti-Xa Activity with Enoxaparin Use in Pregnancy. Society for Maternal-Fetal Medicine 33rd Annual Meeting, San Francisco, CA, February 11–16, 2013.

45 Patil AS, James AH, Small M. Assessment of Maternal Cardiac Dysfunction Following Doxorubicin Exposure: Is Any Level of Exposure During Pregnancy Cardiotoxic? 22nd World Congress on Ultrasound in Obstetrics and Gynecology, Copenhagen, Denmark. September 9–13, 2012.

46 Robinson TJ, Dinan MA, Li Y, Lee WR, Reed SD. Longitudinal trends in costs of palliative radiation for Medicare beneficiaries in the last year of life who died between 2000 and 2007. American Society of Clinical Oncology Annual Meeting, Chicago, IL. May 31–June 4, 2013.

47 Sampson MR, Bloom BT, Anand R, Benjamin DK Jr., Capparelli E, Cohen-Wolkowiez M, Smith PB, Lenfestey RW for the Pediatric Trials Network. Population Pharmacokinetics of Acyclovir in Preterm and Term Infants. Pediatric Academic Societies Annual Meeting, Washington, DC. May 4–7, 2013.

48 Sampson MR, Pene Dumitrescu T, Brouwer KLR, Schmith V. Population Pharmacokinetic Model for Azithromycin in Blood, Peripheral Blood Mononuclear Cells, and Polymorphonuclear Cells of Healthy Adults. American Conference on Pharmacometrics Annual Meeting, Indianopolis, IN. March 5–9, 2013.

49 Shen L, Peterson ED, Li S, Thomas L, Alexander K, Xian Y, Wang TY, Roe MT, He B, Shah BR. The Association Between Smoking and Long-term Outcomes Following Non–ST-Elevation Acute Myocardial Infarction in Older Patients. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

50 Shen L, Shah BR, Nam A, Holmes D, Alexander KP, Bhatt DL, Ho PM, Peterson ED, He B, Roe MT. Prognostic Implications of Prior Myocardial Infarction for Patients Presenting with an Acute Myocardial Infarction. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

51 Shen L, Shah BR, Reyes EM, Thomas L, Diem P, Leiter LA, Charbonnel B, Mareev V, Horton ES, Haffner SM, Soska V, Holman R, Bethel MA, Schaper F, Sun JL, McMurray JJV, Califf RM, Krum H. Role of diuretics, β-blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: insights observations from the NAVIGATOR study. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

52 Sherwood MW, Hellkamp A, Patel MR, Piccini JP, Lokhnygina Y, Douketis J, Becker R, Mahaffey KW, Fox KAA, Califf RM. Outcomes of Temporary Interruption of Rivaroxaban compared with Warfarin in Patients with Nonvavlular Atrial Fibrillation. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

53 Sherwood MW, Wang Y, Curtis JP, Peterson ED, Rao SV. Patterns of red blood cell transfusion use in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights from the NCDR® CathPCI Registry®. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

54 Sherwood MW, Wang TY, Roe MT, Madan P, Peng SA, de Lemos J, Peterson E, Wiviott SD. Patterns of Early Thienopyridine Use among Contemporary STEMI and NSTEMI Patients in the US: Insights from ACTION Registry-Get With The Guidelines. . Scientific Sessions of the American College of Cardiology, Chicago, IL. March 24–27, 2012.

55 Steinberg BA, Al-Khatib SM, Edwards R, Han JY, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman RC, Dorian P, Hallstrom AP, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders G. Implantable Cardiac Defibrillator Therapy in Patients with Comorbidities: Results from a Combined Analysis of Five Randomized Clinical Trials. Scientific Sessions of the Heart Rhythm Society, Denver, CO. May 8–11, 2013.

56 Steinberg BA, Hasselblad V, Atwater BD, Bahnson T, Washam JB, Alexander JH, Daubert JP, Piccini JP. Dabigatran for Periprocedural Anticoagulation Following Radiofrequency Ablation for Atrial Fibrillation: A Meta-Analysis of Observational Studies. Scientific Sessions of the Heart Rhythm Society, Denver, CO. May 8–11, 2013.

57 Steinberg BA, Kim S, Ansell J, Hylek E, Mahaffey KW, Singer DE, Ezekowitz MD, Fonarow GC, Go AS, Kowey P, Thomas L, Chang P, Piccini JP, Peterson ED. High Use of Concomitant Antiplatelet Therapy With Oral Anticoagulation in Patients with Atrial Fibrillation: Results from the ORBIT-AF Registry. Scientific Sessions of the American Heart Association, Los Angeles, CA. November 2–6, 2012.

58 Testoni D, Cohen-Wolkowiez, M, Benjamin Jr, DK, Hornik CP, Clark, RH, Smith, PB, Early and Late Onset Sepsis in Hospitalized Term Infants, Pediatric Research Retreat, Atlanta, GA. January 27, 2012.

59 Virkud Y, Chin S, Kamilaris N, Kulis M, Kamilaris J, Steele P, Smith PB, Vickery BP, Burks AW. (2013, Feb). Predictors of Clinical Tolerance after Peanut Oral Immunotherapy. Poster presented at American Academy of Allergy, Asthma, and Immunology; San Antonio, TX. February 22–26, 2013.

60 Virkud Y, Hornik C, Benjamin D, Laughon M, Clark R, Smith PB. Respiratory Support in Very Low Birth Weight (VLBW) Infants Receiving Dexamethasone. Pediatric Academic Societies Annual Meeting, Washington, DC. May 4–7, 2013.

61 Wong YW, Mi XJ, Fonarow GC, Peacock WF IV, Mills RM, Curtis LH, Qualls LG, Hernandez AF. Early Intravenous Heart Failure Therapy and Outcomes among Older Patients Hospitalized for Acute Decompensated Heart Failure: Analysis of ADHERE Registry Emergency Module. Scientific Sessions of the American College of Cardiology, San Francisco, CA. March 9–11, 2013.

Annual Report of the Academic Output of DCRI Clinical ...

Documents

Transcript of Annual Report of the Academic Output of DCRI Clinical ...